Retroviral transduction of murine and human hematopoietic progenitors and stem cells

Methods in Molecular Biology

Volumn 1185, Issue , 2014, Pages 287-309

  Ciuculescu, Marioara F ^a   Brendel, Christian ^a   Harris, Chad E ^a   Williams, David A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Gene therapy; HSPC isolation; HSPC transduction; Lentiviral vectors; Retroviral vectors

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR; CALCIUM PHOSPHATE; CD34 ANTIGEN; FLUOROURACIL; POLYETHYLENEIMINE;

3T3 CELL LINE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CLONE; CHROMATIN; DNA MODIFICATION; FLOW CYTOMETRY; GENE EXPRESSION; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; POSITION EFFECT VARIEGATION; PRIORITY JOURNAL; SUPERNATANT; TITRIMETRY; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; ANIMAL; CELL LINE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; GENE VECTOR; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; PROCEDURES; RETROVIRUS;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CALCIUM PHOSPHATES; CELL LINE; CELL SEPARATION; FLUOROURACIL; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; POLYETHYLENEIMINE; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84925883522     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1133-2_20     Document Type: Article

References (46)

1. Yin AH, Miraglia S, Zanjani ED et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012
2. Kiel MJ, Yilmaz OH, Iwashita T et al (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109-1121
3. Goodell MA, Brose K, Paradis G et al (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797-1806
4. Spangrude GJ, Johnson GR (1990) Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A 87:7433-7437
5. Osten P, Grinevich V, Cetin A (2007) Viral vectors: a wide range of choices and high levels of service. Handb Exp Pharmacol 178: 177-202
6. Coffi n JM, Hughes SH, Varmus HE (1997) The interactions of retroviruses and their hosts. In: Coffi n JM, Hughes SH, Varmus HE (eds) Retroviruses. Cold Spring Harbor, New York
7. Sommerfelt MA (1999) Retrovirus receptors. J Gen Virol 80:3049-3064
8. Overbaugh J, Miller AD, Eiden MV (2001) Receptors and entry cofactors for retroviruses include single and multiple transmembranespanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev 65:371-389, table of contents
9. Temin HM, Mizutani S (1970) RNAdependent DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211-1213
10. Risco C, Menendez-Arias L, Copeland TD et al (1995) Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J Cell Sci 108:3039-3050
11. Fassati A, Goff SP (1999) Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J Virol 73: 8919-8925
12. Buchschacher GL et al (2004) Safety considerations associated with development and clinical application of lentiviral vector systems for gene transfer. In: Buchschacher G (ed) Current genomics, vol. Bentham Science Publishers, Sharjah, UAE, pp 19-35
13. Maetzig T, Galla M, Baum C et al (2011) Gammaretroviral vectors: biology, technology and application. Viruses 3:677-713
14. Cronin J, Zhang XY, Reiser J (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5:387-398
15. Naldini L, Blomer U, Gallay P et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267
16. Dull T, Zufferey R, Kelly M et al (1998) A thirdgeneration lentivirus vector with a conditional packaging system. J Virol 72:8463-8471
17. Mautino MR, Morgan RA (2002) Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes. AIDS Patient Care STDS 16:11-26
18. Schambach A, Galla M, Modlich U et al (2006) Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol 34:588-592
19. Martinez-Salas E (1999) Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol 10:458-464
20. Szymczak AL, Vignali DA (2005) Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther 5:627-638
21. Fehse B, Uhde A, Fehse N et al (1997) Selective immunoaffi nity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affi nity nerve growth factor receptor (deltaLNGFR) gene. Hum Gene Ther 8:1815-1824
22. Fehse B, Richters A, Putimtseva-Scharf K et al (2000) CD34 splice variant: an attractive marker for selection of gene-modifi ed cells. Mol Ther 1:448-456
23. Schambach A, Bohne J, Baum C et al (2006) Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther 13:641-645
24. Zufferey R, Donello JE, Trono D et al (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892
25. Buchschacher GL Jr (2001) Introduction to retroviruses and retroviral vectors. Somat Cell Mol Genet 26:1-11
26. Hu WS, Pathak VK (2000) Design of retroviral vectors and helper cells for gene therapy. Pharmacol Rev 52:493-511
27. Williams DA, Lemischka IR, Nathan DG et al (1984) Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310:476-480
28. Moritz T, Patel VP, Williams DA (1994) Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451-1457
29. Hanenberg H, Xiao XL, Dilloo D et al (1996) Colocalization of retrovirus and target cells on specifi c fi bronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876-882
30. Donahue RE, Sorrentino BP, Hawley RG et al (2001) Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells. Mol Ther 3:359-367
31. Aiuti A, Cattaneo F, Galimberti S et al (2009) Gene therapy for immunodefi ciency due to adenosine deaminase defi ciency. N Engl J Med 360:447-458
32. Hacein-Bey-Abina S, Hauer J, Lim A et al (2010) Effi cacy of gene therapy for X-linked severe combined immunodefi ciency. N Engl J Med 363:355-364
33. Gaspar HB, Cooray S, Gilmour KC et al (2011) Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodefi ciency. Sci Transl Med 3:97ra79
34. Gaspar HB, Cooray S, Gilmour KC et al (2011) Hematopoietic stem cell gene therapy for adenosine deaminase-defi cient severe combined immunodefi ciency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 3:97ra80
35. Boztug K, Schmidt M, Schwarzer A et al (2010) Stem-cell gene therapy for the Wiskott- Aldrich syndrome. N Engl J Med 363: 1918-1927
36. Aiuti A, Biasco L, Scaramuzza S et al (2013) Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341:1233151
37. Ott MG, Schmidt M, Schwarzwaelder K et al (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12:401-409
38. Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823
39. Biffi A, Montini E, Lorioli L et al (2013) Lentiviral hematopoietic stem cell gene therapy benefi ts metachromatic leukodystrophy. Science 341:1233158
40. Ramezani A, Hawley TS, Hawley RG (2008) Combinatorial incorporation of enhancerblocking components of the chicken beta- globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self- inactivating retroviral vectors reduces their genotoxic potential. Stem Cells 26:3257-3266
41. Gaussin A, Modlich U, Bauche C et al (2012) CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors. Gene Ther 19:15-24
42. Koldej RM, Carney G, Wielgosz MM et al (2013) Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors. Hum Gene Ther Clin Dev 24:77-85
43. Pfaff N, Lachmann N, Ackermann M et al (2013) A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31:488-499
44. Zhang F, Frost AR, Blundell MP et al (2010) A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation- mediated silencing of lentiviral vectors. Mol Ther 18:1640-1649
45. Zhang F, Thornhill SI, Howe SJ et al (2007) Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 110:1448-1457
46. McDermott SP, Eppert K, Lechman ER et al (2010) Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 116:193-200